Twist Bioscience Corporation
TWST
$55.95
-$0.26-0.46%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -44.02M | -30.51M | -27.14M | 20.39M | -39.33M |
| Total Depreciation and Amortization | 6.21M | 5.89M | 3.10M | 6.07M | 6.20M |
| Total Amortization of Deferred Charges | 200.00K | 300.00K | 2.90M | -- | 200.00K |
| Total Other Non-Cash Items | 18.44M | 12.94M | 16.30M | -31.64M | 21.16M |
| Change in Net Operating Assets | 1.61M | -13.44M | -6.98M | 3.78M | -1.22M |
| Cash from Operations | -17.56M | -24.81M | -11.81M | -1.40M | -12.99M |
| Capital Expenditure | -7.89M | -9.97M | -12.43M | -9.17M | -4.14M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | 0.00 | 2.50M | -- |
| Other Investing Activities | -4.82M | 41.00K | 24.00K | -2.73M | 2.72M |
| Cash from Investing | -12.71M | -9.93M | -12.40M | -9.40M | -1.43M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.15M | 300.00K | 5.58M | 1.83M | 3.20M |
| Repurchase of Common Stock | -8.00K | -2.00K | -2.00K | -3.00K | -5.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 0.00 | 0.00 |
| Cash from Financing | 4.14M | 298.00K | 5.57M | 1.83M | 3.20M |
| Foreign Exchange rate Adjustments | -6.00K | 9.00K | 163.00K | -71.00K | 104.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -26.13M | -34.44M | -18.48M | -9.04M | -11.11M |